| 
                  
                    | 
 Pei-Hsing Chen
 | 
                        
                          | Download : |  |  |  
                    |  |  
                    | 
                        
                          |  | 
                              
                                |  | Current position: |  
                                |  | 
                                    Attending Physician, Department of Surgery, National Taiwan University
                                      Hospital.
                                     |  
                                |  | Specialty: 
 |  
                                |  | 
                                    Consultation on Pulmonary Nodules, Tumors, Cancer Screening, and Health Checkup
                                      ResultsMinimally Invasive Endoscopic Surgery (for Lung Cancer, Esophageal Cancer,
                                      Metastatic Lung Cancer)Surgeries for Lung Nodules, Lung Cancer, Esophageal Tumors, Esophageal Cancer,
                                      Mediastinal Tumors, Thymus, Tracheal Tumors, and Chest Wall Tumors, and more.Thoracic Cavity Diseases including Empyema, Pneumothorax, Hemothorax, Chest
                                      Trauma, Rib Fractures, and more |  
                                |   | Education: |  
                                |  | 
                                    Ph.D. candidate, Department of Biomedical Engineering, National Taiwan
                                      University.MD, School of Medicine, College of Medicine, National Taiwan University |  
                                |   | Career and
                                      certification: |  
                                |  | 
                                    Attending Physician, Department of Surgery, National Taiwan University Hospital
                                      Hsinchu Branch
                                    Attending Physician, Department of Surgery, National Taiwan University Hospital
                                      Yunlin BranchChief Surgeon of Thoracic Surgery, National Taiwan University Hospital
                                    Research Physician in Thoracic Surgery at Kyoto University Hospital, Japan
                                     |  
                                |  | Reminder from Dr. Chen: |  
                                |  | 
                                    Over the past decade, lung cancer has consistently been the leading cause of cancer
                                    death in Taiwan, earning the moniker "Taiwan's new national disease." The terror of
                                    lung cancer lies in its initially inconspicuous symptoms, with most patients only
                                    seeking medical attention when they experience significant discomfort, by which time
                                    the disease has often progressed to a mid or late stage, significantly lowering
                                    survival rates. In response to the significant threat lung cancer poses to the
                                    Taiwanese population, the country has recently implemented low-dose chest CT scans
                                    for screening. Compared to traditional chest X-rays, this method more easily detects
                                    small pulmonary nodules (larger than 0.3 cm), offering increased opportunities for
                                    early diagnosis of lung cancer through screening. It's recommended to immediately
                                    consult a thoracic medicine or thoracic surgery specialist for further diagnosis if
                                    a pulmonary nodule larger than 0.5 cm is encountered.
                                    Online Registration:
                                  Register
 Modern treatments for lung cancer are increasingly advanced. If the patient's
                                    condition allows, localized surgical treatment is generally recommended. This
                                    method, which involves removing the tumor and lymph nodes and determining the stage
                                    of lung cancer, is the best approach for prognosis. However, for patients with poor
                                    cardiopulmonary function or advanced age, options like radiation therapy or ablation
                                    therapy are also viable. For advanced lung cancer, in addition to traditional
                                    chemotherapy, targeted therapy and immunotherapy are now available, offering more
                                    hope to patients in advanced stages. The specific treatment method should be
                                    determined in consultation with an experienced and professional medical team to
                                    achieve the best treatment outcome.
 |  |      |  
                    |  |  |